Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
Eva Hoster(Zimmer Biomet (Germany)), Michael Unterhalt, Stephan Stilgenbauer(Universität Ulm), Vincent Ribrag(Institut Gustave Roussy), Catherine Thiéblemont(Assistance Publique – Hôpitaux de Paris), Francesco Di Raimondo(Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen), Martin Dreyling(LMU Klinikum), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Michał Szymczyk(The Maria Sklodowska-Curie National Research Institute of Oncology), Olivier Hermine(Délégation Paris 5), Michael Hallek(University of Cologne), Marek Trněný(The University of Texas System), Christian H. Geisler(Rigshospitalet), Achiel Van Hoof(AZ Sint-Jan), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Jeanette K. Doorduijn(Université Paris Cité), Christiane Pott(University Hospital Schleswig-Holstein), Roswitha Forstpointner(LMU Klinikum)
Cited by 164
Related Papers
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k